Navigation Links
XTend Medical (XDMC) Adds New Bluetooth(R) Telemedicine Products From A&D Medical
Date:10/18/2007

Bluetooth(R) Wireless Blood Pressure Cuff and Weight Scale Added to Our

Telemedicine Product Line

SUN VALLEY, Calif., Oct. 18 /PRNewswire-FirstCall/ -- XTend Medical Corporation (Pink Sheets: XMDC) announced the company has added two new Bluetooth(R) enabled telemedicine products to their line of disease management solutions for sales to managed care, hospitals, long term care facilities, and physician groups.

"The addition of A & D's Bluetooth(R) enabled Blood Pressure Cuff and Weight Scale will give us the opportunity to package our offerings to the various healthcare organizations in order to effectively monitor their patients with the most up to date technology in the healthcare arena. As we target the larger managed health care companies, this technology allows us to not only target diabetic patients, our main focus, but also gives us the ability to present to managed care companies a cutting-edge solution for chronic conditions in heart and kidney patients. This increases our opportunity to generate significant sales and imbeds us further with gaining additional long term contracts. XTend Medical, through R&D expenditures and exclusive agreements, continues to ensure our position as a leading provider of telemedicine products and services for years to come," stated Mr. Paul D. Lisenby, Chairman and CEO of XTend Medical.

About A & D:

A&D Medical is a division of A&D, an ISO 9002-registered company with operations in Asia, Europe, Australia, Russia, and North and South America. Since 1977, A&D Medical has manufactured and distributed a full line of advanced electronic blood pressure monitoring equipment and health care products for home and professional use. The company has established itself as a leader in home health monitoring technology through the development and introduction of a variety of unique products. A&D's LifeSource(R) blood pressure monitor line has garnered numerous industry awards. Recent product introductions include: the LifeSource(R) digital thermometers, personal scales, stethoscopes, and Ambulatory Blood Pressure Monitors.

For more information, please check out our website, http://www.andmedical.com.

About XTend Medical:

XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients.

For more information about the Company, please visit http://www.xtendmedical.com.

Safe Harbor: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Company Contact: FutureTechIR for XTend Medical Corporation

Investor Relations

(817) 812-2105


'/>"/>
SOURCE XTend Medical Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. Liver key to extending life
3. Regular exercise linked to extended menstrual cycles
4. Even mid-life diet change can extend life
5. Extended Therapy for Blood Clots
6. Friendship can extend lifespan
7. Genes to Extend Longevity Discovered
8. India extends National TB Control Program
9. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
10. Drug Courts In Europe Extended For Three More Years
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... over twenty-four years, Doctors on Liens has published a directory of the top ... care. When the company started in 1997, the directory was a single page focusing ... now ten-page directory features a vast array of medical specialists stretching from Sacramento ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to ... Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to ... drug plan (Part D) need to make changes during this period order for their ...
(Date:12/2/2016)... NY (PRWEB) , ... December 02, 2016 , ... More ... school and while 84 percent of parents report speaking with their child about sex ... and sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre ... unique properties including its unmatched natural purity of just 6 ppm TDS (Total Dissolved ... , Nothing Water has been available in several ShopRite and FoodTown stores in NJ ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare ... the honor of being selected as winners of multiple ... Healthcare Executives Website at the PLATINUM level, Blue Zones ... Module at the GOLD Level, and our proprietary 3ConneX ... At Simpson Healthcare Executives, we are excited to showcase ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
(Date:12/2/2016)... 2, 2016 Allergan plc (NYSE: AGN ... on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a variable ... Company will repurchase $10 billion of its ordinary shares. Approximately ...
Breaking Medicine Technology: